![]() |
Aprotinin (Injection)AprotininPrevents blood loss and reduces the need for blood transfusions during and after heart bypass operations. Products containing aprotinin (Trasylol®) were withdrawn from the U.S. market by Bayer Pharmaceuticals on November 5, 2007. This medicine is only available on a very limited basis for patients who are at increased risk of blood loss during heart bypass surgery and who have no other treatment choices.Brand Name(s):TrasylolThere may be other brand names for this medicine.When This Medicine Should Not Be Used:You should not receive this medicine if you have had an allergic reaction to aprotinin, or if you have received aprotinin within the last 12 months.How to Use This Medicine:Injectable
Drugs and Foods to Avoid:Ask your doctor or pharmacist before using any other medicine, including over-the-counter medicines, vitamins, and herbal products.
Warnings While Using This Medicine:
Possible Side Effects While Using This Medicine:Call your doctor right away if you notice any of these side effects:
If you notice these less serious side effects, talk with your doctor:
Last Updated: 6/12/2013 The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. All rights reserved ![]() A.D.A.M. content is best viewed in IE9 or above, Firefox and chrome browser. |